8-K
filed October 21, 2022, 7:59 PM ET
ticker INVE
CIK 0001036044
leadership
confidence high
sentiment neutral
materiality 0.50
Identiv appoints Angelini and Kuntz to board after resignations of Braun and Shapiro
Identiv, Inc.
- Robin R. Braun and Nina B. Shapiro resigned from the board effective October 17, 2022.
- Board appointed Laura Angelini (former Baxter GM) and Dr. Richard E. Kuntz (former Medtronic exec) on October 18.
- Angelini and Kuntz bring healthcare, medical device, and global business expertise.
- Both will receive standard non-employee director compensation (RSUs and cash) per Identiv's proxy.
- No arrangements or transactions requiring disclosure under Item 404(a) exist.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard E. Kuntz was appointed as Director at Identiv, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On October 18, 2022, the Board appointed Laura Angelini and Richard E. Kuntz, M.D., M.Sc. to serve as members of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nina B. Shapiro resigned as Director at Identiv, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 17, 2022, Robin R. Braun and Nina B. Shapiro resigned from the board of directors (the "Board") of Identiv, Inc. (the "Company"), including all committees thereof, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robin R. Braun resigned as Director at Identiv, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 17, 2022, Robin R. Braun and Nina B. Shapiro resigned from the board of directors (the "Board") of Identiv, Inc. (the "Company"), including all committees thereof, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Laura Angelini was appointed as Director at Identiv, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On October 18, 2022, the Board appointed Laura Angelini and Richard E. Kuntz, M.D., M.Sc. to serve as members of the Board.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.